Peer review reports
From: The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants < 29 weeks’ gestation
Original Submission |
24 Sep 2015 |
Submitted |
Original manuscript
|
15 Feb 2016 |
Author responded |
Author comments - Carmel Collins
|
Resubmission - Version 2 |
15 Feb 2016 |
Submitted |
Manuscript version 2
|
Publishing |
27 May 2016 |
Editorially accepted |
|
1 Jun 2016 |
Article published |
10.1186/s12887-016-0611-0
|
Learn about peer review